Vasodilators and low-dose acetylsalicylic acid are associated with a lower incidence of distinct primary myocardial disease manifestations in systemic sclerosis: results of the DeSScipher inception cohort study
Gabriele Valentini, Dörte Huscher, Antonella Riccardi, Serena Fasano, Rosaria Irace, Valentina Messiniti, Marco Matucci-Cerinic, Serena Guiducci, Oliver Distler, Britta Maurer, Jérôme Avouac, Ingo H Tarner, Marc Frerix, Gabriela Riemekasten, Elise Siegert, László Czirják, Veronika Lóránd, Christopher P Denton, Svetlana Nihtyanova, Ulrich A Walker, Veronika K Jaeger, Francesco Del Galdo, Giuseppina Abignano, Lidia P Ananieva, Ana Maria Gherghe, Carina Mihai, Joerg Christoph Henes, Tim Schmeiser, Alessandra Vacca, Sergey Moiseev, Ivan Foeldvari, Armando Gabrielli, Brigitte Krummel-Lorenz, Simona Rednic, Yannick Allanore, Ulf Müeller-Ladner
Annals of the Rheumatic Diseases Nov 2019, 78 (11) 1576-1582; DOI: 10.1136/annrheumdis-2019-215486
